What Is Baclofen and How Does It Work?

Baclofen is a prescription antispastic medication used to reduce muscle stiffness, involuntary spasms and associated pain in people with certain neurological conditions. It is particularly useful in treating spasticity caused by multiple sclerosis and may also benefit patients with spinal cord injuries or other diseases affecting the spinal cord.

What Clinicians Consider Before Prescribing Baclofen

Two patients with similar muscle tightness may need entirely different treatments. Before prescribing baclofen, clinicians consider the cause of spasticity, how it affects everyday movement and whether reducing muscle tone is likely to improve function. A medication that helps one patient walk more comfortably could make another feel less stable if too much supporting muscle tone is removed.

What Conditions Does Baclofen Treat?

The FDA-approved labeling for oral baclofen focuses on spasticity associated with multiple sclerosis. It also identifies possible benefit in patients with spinal cord injuries and other spinal cord diseases. The medication treats symptoms caused by abnormal muscle tone; it does not reverse the neurological injury responsible for them.

Spasticity in Multiple Sclerosis

Multiple sclerosis (MS) can damage the protective covering of nerve fibers in the central nervous system. When signals between the brain, spinal cord and muscles become disrupted, some muscles may remain unusually tight or contract without voluntary control. Spasticity is especially troublesome when it affects the legs, although other muscle groups can also be involved.

Baclofen is used to relieve flexor spasms, clonus, rigidity and associated pain. Clonus refers to repeated involuntary muscle contractions that may occur when a muscle is stretched. For a patient with MS, these problems can interfere with sleeping comfortably, getting dressed, transferring from a wheelchair or completing physical therapy exercises.

The benefits must be assessed against possible weakness. Some people with MS use a degree of increased muscle tone to support standing or walking. Relaxing those muscles too much can make movement more difficult, even when the number of spasms decreases. A successful treatment plan therefore considers what the patient can actually do, not only how relaxed the muscles feel during an examination.

Spasticity Following Spinal Cord Injury

Spinal cord injuries can interrupt the pathways that normally regulate muscle reflexes. Below the level of injury, muscles may develop increased tone, involuntary contractions or exaggerated responses to movement and touch. These symptoms can make sitting, positioning and personal care difficult, and severe spasms may become painful.

Baclofen can help reduce excessive reflex activity in selected patients. Treatment is often coordinated with physical rehabilitation, stretching, positioning and other measures intended to maintain mobility and prevent complications.

Oral baclofen tablets are not indicated for routine skeletal muscle spasms caused by rheumatic disorders. The labeling also states that effectiveness has not been established for spasticity associated with stroke, cerebral palsy or Parkinson’s disease and does not recommend the tablets for those conditions. Clinicians may sometimes prescribe medicines outside their approved indications, but such decisions require a separate assessment rather than assuming all muscle stiffness responds to the same treatment.

Baclofen Dosage: 5 mg, 10 mg and 20 mg

Baclofen tablets are available in the United States in strengths of 5 mg, 10 mg and 20 mg. The prescribed amount is usually increased gradually because the nervous system effects can become difficult to tolerate when treatment begins at a high dose.

The official tablet prescribing information describes a suggested adult titration schedule beginning with 5 mg three times daily for three days. The dose may then be increased to 10 mg three times daily, followed by 15 mg and 20 mg three times daily, with approximately three days at each stage. This schedule is a prescribing reference, not a requirement that every patient reach the highest step. People who respond well at a lower amount may remain there, and some patients need a slower increase.

In the reviewed tablet labeling, the maximum recommended total daily dose is 80 mg, usually divided into several doses. Kidney impairment, age, concurrent medicines and excessive sedation may call for substantially different decisions. The prescribed dose should always reflect individual clinical circumstances.

It can take time to establish whether baclofen is producing the right balance between spasm relief and muscle strength. Patients may notice that tightness decreases before they know whether walking or transfers are actually easier. Persistent dizziness, pronounced weakness or daytime sleepiness can indicate that the regimen needs reassessment.

Taking Baclofen Tablets Safely

Oral baclofen is commonly taken in divided doses. Consistent timing helps maintain the prescribed treatment schedule, especially in patients whose spasms occur throughout the day.

• Take baclofen at the times and in the amounts specified on the prescription.
• Do not increase the dose after a particularly uncomfortable episode of muscle spasticity.
• If a dose is missed, follow the prescribed instructions and never double a dose to compensate.
• Avoid driving or operating dangerous machinery until the effects on alertness and coordination are known.
• Report weakness, repeated falls or sedation that interferes with rehabilitation or normal daily activities.

A patient who experiences little benefit after an appropriate trial should be reassessed rather than continue increasing the dose. If treatment is no longer suitable, discontinuation normally requires gradual reduction.

Why Baclofen Should Not Be Stopped Suddenly

One of the most important precautions with baclofen is the risk of withdrawal after abrupt discontinuation. The medication changes activity within the central nervous system, and stopping regular treatment without an appropriate reduction can lead to serious symptoms.

Sudden withdrawal from oral baclofen has been associated with hallucinations, seizures, confusion and a marked return of spasticity. Some patients may experience fever, agitation or severe muscle stiffness. These symptoms should not be mistaken for ordinary discomfort after missing a muscle relaxant.

Patients taking baclofen regularly should not stop it abruptly unless a clinician determines that an emergency change is necessary.

The risk is particularly severe with intrathecal baclofen, which is delivered directly into the fluid surrounding the spinal cord by an implanted pump. An interruption caused by pump malfunction, an empty reservoir or catheter problems can produce rapidly worsening spasticity, high fever, altered mental status and potentially life-threatening complications.

Oral and intrathecal withdrawal are not identical situations, but both require attention. Patients who have missed several oral doses or developed possible withdrawal symptoms should obtain medical advice promptly. Severe confusion, seizures or rapidly deteriorating symptoms require emergency evaluation.

Baclofen Side Effects and Serious Reactions

The same central nervous system effects that make baclofen useful for spasticity can also reduce alertness, coordination and muscle strength. Side effects are often most noticeable after treatment begins or the dose increases. Their clinical significance depends on the patient: mild sleepiness may be manageable for one person but create substantial fall risk for someone who already has limited mobility.

Common Side Effects

Drowsiness is the most frequently reported adverse reaction in the prescribing information. Dizziness, fatigue and muscle weakness are also common. Some patients experience nausea, constipation, headache or problems with balance and concentration.

• Sleepiness or reduced daytime alertness
• Dizziness and impaired coordination
• Muscle weakness or unusual fatigue
• Nausea or constipation
• Headache, confusion or difficulty concentrating

These effects may improve as the patient adjusts to treatment, but that is not guaranteed. Weakness deserves particular attention. If a person can no longer stand or transfer safely after starting baclofen, the reduction in muscle tone may be interfering with function rather than improving it. Repeated falls, persistent sedation or new confusion warrant medical assessment.

Signs of Overdose and When to Seek Emergency Care

Excessive baclofen exposure can cause profound central nervous system depression. Severe overdose may result in marked muscle weakness, vomiting, very low responsiveness, respiratory depression, seizures or coma. The risk can be greater when kidney function is impaired or when baclofen is combined with other sedating medicines.

The following symptoms require emergency medical care:

• Difficulty waking the patient or loss of consciousness
• Slow, shallow or otherwise impaired breathing
• Seizures or sudden severe neurological changes
• Profound weakness accompanied by reduced responsiveness
• Severe confusion or hallucinations, particularly after an interruption in treatment

Suspected overdose should not be managed by allowing someone to sleep until the medication wears off. Emergency assessment is necessary because breathing and consciousness can deteriorate.

Baclofen Precautions and Drug Interactions

Baclofen requires additional caution in patients with impaired kidney function, seizure disorders or medical conditions that already affect alertness and balance. It is contraindicated in people with known hypersensitivity to baclofen.

Baclofen and Kidney Disease

Most baclofen is eliminated through the kidneys, largely without being chemically changed. When renal function declines, the medication may remain in the body longer, increasing its effects on the central nervous system. A dose tolerated by someone with normal kidney function can produce excessive drowsiness, confusion or other signs of toxicity in a patient with significant kidney impairment.

This is particularly important in advanced chronic kidney disease and in patients receiving dialysis. Clinicians may need to use a reduced dose or consider another treatment, depending on the extent of impairment and the individual patient’s circumstances. Changes in alertness after a recent dose increase should prompt closer attention when kidney disease is present.

Kidney function can be evaluated through laboratory testing, including serum creatinine and estimated glomerular filtration rate (eGFR). Readers seeking an explanation of these measurements can review Understanding Common Blood Tests and What They Measure.

Patients should tell their prescriber if kidney function has changed since baclofen was first prescribed. A previously suitable regimen may need reassessment as other medical conditions develop.

Alcohol, Sedatives and Other Medicines

Alcohol can intensify the sedating effects of baclofen. Similar concerns apply to opioids, benzodiazepines, sleeping medications, sedating antihistamines and certain other drugs that depress central nervous system activity. Combining these substances can worsen coordination, increase fall risk and, in severe circumstances, contribute to dangerous respiratory depression.

Patients should also disclose medicines used for seizures, psychiatric conditions and blood pressure control. The interaction risk is not limited to long-term prescriptions. An over-the-counter nighttime cold remedy or a newly prescribed pain medication may contain sedating ingredients that were not part of the original treatment plan.

For people with epilepsy, the prescribing information recommends appropriate clinical monitoring because changes in seizure control have occasionally been reported.

Pregnancy, Breastfeeding and Children

Use of oral baclofen during pregnancy requires an assessment of potential benefits and risks. Newborn withdrawal symptoms, including increased muscle tone, tremor, irritability and seizures, have been reported after maternal treatment throughout pregnancy. Someone who becomes pregnant while taking baclofen should contact the treating clinician rather than discontinue the medication abruptly.

Information about breastfeeding is more specific than earlier drug labeling alone might suggest. The NIH LactMed database reports that oral baclofen appears in breast milk at relatively low levels and is not expected to cause adverse effects in most breastfed infants, especially those older than two months. Newborn infants should nevertheless be monitored for unusual sedation. Decisions should consider the dose, the infant’s age and other medicines the mother may be taking.

For the reviewed oral tablet labeling, safety and effectiveness have not been established in children younger than 12 years. Pediatric treatment requires an indication-specific clinical decision rather than simply applying an adult dose.

Oral Baclofen vs Intrathecal Baclofen

Baclofen can be administered in different ways. Oral tablets are commonly used for outpatient treatment and allow gradual adjustments according to response. Oral liquid formulations may be suitable when a patient has difficulty swallowing tablets or requires another method of measuring the prescribed dose.

Intrathecal baclofen is different. It is delivered directly into the cerebrospinal fluid, usually through a surgically implanted pump, and is considered for selected patients with severe spasticity when other treatment approaches have not produced an adequate result or have caused unacceptable side effects.

Because the drug is delivered near the spinal cord, intrathecal doses are much smaller than oral doses and cannot be converted by simply using the same number of milligrams. Pump treatment requires specialist assessment, programming, refills and ongoing monitoring.

Interruptions in intrathecal delivery can create an acute medical emergency. Patients and caregivers need to recognize warning signs of pump or catheter problems and know how to contact the treating team. Oral tablets should not be used as an improvised replacement for a disrupted pump without specialist instructions.

Medical Disclaimer

This article provides general information about baclofen, its approved uses, dosing principles, adverse effects and safety precautions. It does not replace a diagnosis or individualized treatment plan. The appropriate treatment depends on the cause of muscle spasticity, medical history, kidney function, other medications and functional goals.

Do not begin, increase or abruptly discontinue baclofen without professional medical guidance. Loss of consciousness, breathing difficulty, seizures, suspected overdose or severe withdrawal symptoms require emergency medical attention.

Frequently Asked Questions About Baclofen

Related Spasticity and Medication Monitoring Information

Long-term treatment of neurological spasticity may involve medication review, rehabilitation and periodic evaluation of other medical conditions. The following Sweetwater Medical Center resources explain how laboratory testing and regular clinical assessment contribute to patient care.

• Understanding Common Blood Tests and What They Measure
• How Our Laboratory Helps Physicians Make Faster Diagnoses
• The Annual Check-Up Most Adults Skip and Why It Matters

Medical References

DailyMed: Baclofen Tablets Prescribing Information

MedlinePlus: Baclofen Drug Information

NIH LactMed: Baclofen and Breastfeeding

Pharmacist Review of Baclofen Information

The previously published medication information on this page, including baclofen’s approved uses, prescription status, U.S. tablet strengths, titration, maximum labeled dosage, renal precautions, withdrawal risk, central nervous system effects, interactions and overdose warnings, was reviewed by Jeffrey Collins, PharmD, Pharmacist – Wyoming Pharmacist License 3836; NPI 1255701884.

The original pharmacist review date is preserved from the previously published page. The subsequent editorial revision of this article does not establish that the revised content has undergone a new independent pharmacist review.

Last pharmacist review: 08.05.2026.

Article Update: October 23, 2026

This article was editorially updated on October 23, 2026, using U.S. prescribing information and patient medication references. The revision clarifies baclofen’s role in neurological spasticity, gradual dose adjustment, kidney-related precautions and the risks associated with abrupt withdrawal.

2026 prescribing information: DailyMed updated the baclofen tablet listing distributed by Golden State Medical Supply, Inc. on April 21, 2026. The listing confirms oral tablet strengths of 5 mg, 10 mg and 20 mg, as well as the established information on individual dose titration and a maximum labeled daily dose of 80 mg. The record is a repackaged generic product label and does not establish a newly approved indication or a new safety finding for baclofen.

Source: DailyMed – Baclofen Tablets, Golden State Medical Supply, updated April 21, 2026.